BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33096337)

  • 1. Classification of gastric cancers based on immunogenomic profiling.
    Liu Z; Jiang Z; Wu N; Zhou G; Wang X
    Transl Oncol; 2021 Jan; 14(1):100888. PubMed ID: 33096337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of triple-negative breast cancers based on Immunogenomic profiling.
    He Y; Jiang Z; Chen C; Wang X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):327. PubMed ID: 30594216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel immune subtypes identification of HER2-positive breast cancer based on immunogenomic landscape.
    Huang L; Liu X; Li L; Wang L; Wu N; Liu Z
    Med Oncol; 2022 May; 39(5):92. PubMed ID: 35568771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenomic Profiling and Classification of Prostate Cancer Based on HIF-1 Signaling Pathway.
    Song J; Chen W; Zhu G; Wang W; Sun F; Zhu J
    Front Oncol; 2020; 10():1374. PubMed ID: 32850440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma.
    Liu Q; Nie R; Li M; Li L; Zhou H; Lu H; Wang X
    Comput Struct Biotechnol J; 2021; 19():4472-4485. PubMed ID: 34471493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of Osteosarcoma Based on Immunogenomic Profiling.
    Wang X; Wang L; Xu W; Wang X; Ke D; Lin J; Lin W; Bai X
    Front Cell Dev Biol; 2021; 9():696878. PubMed ID: 34336848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying Immune-Specific Subtypes of Adrenocortical Carcinoma Based on Immunogenomic Profiling.
    Lu Q; Nie R; Luo J; Wang X; You L
    Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironment characterization in stage IV gastric cancer.
    Zhang X; Yang F; Wang Z
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33416081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of molecular features correlating with tumor immunity in gastric cancer by multi-omics data analysis.
    He Y; Wang X
    Ann Transl Med; 2020 Sep; 8(17):1050. PubMed ID: 33145269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling.
    Wei Y; Ou T; Lu Y; Wu G; Long Y; Pan X; Yao D
    PeerJ; 2020; 8():e10414. PubMed ID: 33282564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of stem cell-related subtypes and risk scoring for gastric cancer based on stem genomic profiling.
    Xiang R; Song W; Ren J; Wu J; Fu J; Fu T
    Stem Cell Res Ther; 2021 Oct; 12(1):563. PubMed ID: 34717747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy.
    Xu F; Chen JX; Yang XB; Hong XB; Li ZX; Lin L; Chen YS
    Mol Ther Oncolytics; 2020 Jun; 17():241-249. PubMed ID: 32346613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling.
    Zhou X; Qiu S; Nie L; Jin D; Jin K; Zheng X; Yang L; Wei Q
    Front Oncol; 2020; 10():1429. PubMed ID: 32974156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gastric cancer subtypes based on pathway clustering.
    Li L; Wang X
    NPJ Precis Oncol; 2021 Jun; 5(1):46. PubMed ID: 34079012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unsupervised Hierarchical Clustering Identifies Immune Gene Subtypes in Gastric Cancer.
    Cao J; Gong J; Li X; Hu Z; Xu Y; Shi H; Li D; Liu G; Jie Y; Hu B; Chong Y
    Front Pharmacol; 2021; 12():692454. PubMed ID: 34248641
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
    Companioni O; Sanz-Anquela JM; Pardo ML; Puigdecanet E; Nonell L; García N; Parra Blanco V; López C; Andreu V; Cuatrecasas M; Garmendia M; Gisbert JP; Gonzalez CA; Sala N
    PLoS One; 2017; 12(4):e0176043. PubMed ID: 28441455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer.
    Jiang Z; Liu Z; Li M; Chen C; Wang X
    Transl Oncol; 2018 Oct; 11(5):1171-1187. PubMed ID: 30059832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined immune and DDR pathway classifier: A novel pathway-based classification aimed at tailoring personalized therapies for acute myeloid leukemia patients.
    Huang Y; Zhang Y; Zhou Q; Teng Y; Sui M; Zhang F
    Comput Biol Med; 2023 Aug; 162():107093. PubMed ID: 37269679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling cancer-associated genetic alterations and molecular classification of cancer in Korean gastric cancer patients.
    Kim Y; Cho MY; Kim J; Kim SN; Oh SC; Lee KA
    Oncotarget; 2017 Sep; 8(41):69888-69905. PubMed ID: 29050249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
    Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
    Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.